10月31日连板股分析：连板股晋级率33% 创新药概念股全线爆发

Core Insights - The article highlights a significant surge in the stock market, particularly focusing on the performance of consecutive limit-up stocks, with a promotion rate of 33.33% among these stocks [1] Group 1: Stock Performance - A total of 57 stocks hit the daily limit, with 9 consecutive limit-up stocks, including 4 stocks achieving three consecutive limit-ups or more [1] - The market saw over 3,700 stocks rising, indicating a strong performance from small-cap stocks [1] - Notable stocks include Time Space Technology, which advanced to 8 consecutive limit-ups, and Ruilite, which reached 4 consecutive limit-ups [1] Group 2: Sector Performance - The innovative drug sector experienced a broad rally, with nearly 20 stocks either hitting the limit or rising over 10%, including Sangfor Technologies and Shuyitai, both hitting the 20% limit [1] - AI application stocks showed strong fluctuations, with notable performances from Foxit Software, which surged nearly 40% over two days, and 360 Security Technology hitting the limit [1]